{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:14Z","timestamp":1786115054683,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Renal Sarcoidosis is a rare disease and poorly described. We aimed to characterise the clinical presentation, histopathology, treatment response, and renal outcomes in patients with biopsy proven renal sarcoidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational study with biopsy-proven kidney disease in sarcoidosis, assessing demographics, clinical presentation, histology, treatments, and outcomes. Progression to CKD stage 4\/5 or requiring dialysis was the primary outcome. Group comparisons and Cox proportional hazards models were used to identify predictors of the primary outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 32 patients, 44% presented with kidney disease. In others, it was noted 2.5 years after diagnosis of extra-renal sarcoidosis. Granulomatous interstitial nephritis was the most common histology seen (59.4%). Steroids were used in 78.1%, predominantly prednisolone; 56% received high-dose regimen (30\u00a0mg\/day or more). Over a follow up of 6 years, 9 patients experienced CKD 4\/5. Patients who developed primary outcome had significantly lower eGFR at the time of presentation to nephrologist (median 20 vs. 43 mL\/min,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049), and in univariate Cox analysis, younger age at diagnosis was associated with primary outcome (HR 0.95, 95% CI 0.91\u20131.00;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039). During follow up, 10 (31%) patients developed relapse, 4 (12.5%) patients progressed to ESKD, and 3 (9%) patients died.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Renal sarcoidosis is associated with incomplete renal recovery and carries a substantial risk of progression to advanced CKD or ESKD. Younger age and severe renal impairment at presentation were associated with poor renal outcomes, although these findings should be interpreted with caution. Our findings underscore the need for early diagnosis, structured follow-up, and multicentre prospective registries to refine prognostic tools and guide long-term care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05057-y","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:36:09Z","timestamp":1780385769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kidneys in the crossfire: insights into renal sarcoidosis"],"prefix":"10.1186","volume":"27","author":[{"given":"Zainah","family":"Sindhoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9699-5357","authenticated-orcid":false,"given":"Mohammed Askari","family":"Meghji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazar","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga A. K.","family":"Kanigicherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"4","key":"5057_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells10040766","volume":"10","author":"P S\u00e8ve","year":"2021","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, et al. Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells. 2021;10(4):766. https:\/\/doi.org\/10.3390\/cells10040766.","journal-title":"Cells"},{"issue":"3","key":"5057_CR2","doi-asserted-by":"publisher","first-page":"2300198","DOI":"10.1183\/13993003.00198-2023","volume":"62","author":"S Dhooria","year":"2023","unstructured":"Dhooria S, Sehgal IS, Agarwal R, Muthu V, Prasad KT, Dogra P, et al. High-dose (40 mg) versus low-dose (20\u00a0mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial). Eur Respir J. 2023;62(3):2300198. https:\/\/doi.org\/10.1183\/13993003.00198-2023.","journal-title":"Eur Respir J"},{"issue":"2","key":"5057_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.31083\/j.rcm2502037","volume":"25","author":"A Vereckei","year":"2024","unstructured":"Vereckei A, Besenyi Z, Nagy V, Radics B, V\u00e1g\u00f3 H, Jenei Z, et al. Cardiac Sarcoidosis: A Comprehensive Clinical Review. Rev Cardiovasc Med. 2024;25(2):37. https:\/\/doi.org\/10.31083\/j.rcm2502037. PubMed PMID: 39077350; PubMed Central PMCID: PMC11263157.","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"5057_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234\u201341. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009096. PubMed PMID: 9012596.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5057_CR5","first-page":"128","volume":"30","author":"MH Tukey","year":"2013","unstructured":"Tukey MH, Berman JS, Boggs DA, White LF, Rosenberg L, Cozier YC. Mortality among African American women with sarcoidosis: data from the Black Women\u2019s Health Study. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2013;30(2):128\u201333. PubMed PMID: 24071884; PubMed Central PMCID: PMC3801105.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"5057_CR6","doi-asserted-by":"publisher","unstructured":"Tana C, Drent M, Nunes H, Kouranos V, Cinetto F, Jessurun NT et al. Comorbidities of sarcoidosis. Ann Med. 54(1):1014\u201335. https:\/\/doi.org\/10.1080\/07853890.2022.2063375 PubMed PMID: 35441568; PubMed Central PMCID: PMC9891229.","DOI":"10.1080\/07853890.2022.2063375"},{"issue":"1","key":"5057_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","volume":"24","author":"P Sakthivel","year":"2017","unstructured":"Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol. 2017;24(1):59. https:\/\/doi.org\/10.1097\/MOH.0000000000000301.","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"5057_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/jcm9041081","volume":"9","author":"R Jain","year":"2020","unstructured":"Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J Clin Med. 2020;9(4):1081. https:\/\/doi.org\/10.3390\/jcm9041081. PubMed PMID: 32290254; PubMed Central PMCID: PMC7230978.","journal-title":"J Clin Med"},{"key":"5057_CR9","doi-asserted-by":"publisher","unstructured":"Lhote R, Annesi-Maesano I, Nunes H, Launay D, Borie R, Sacr\u00e9 K, et al. Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort. Eur Respir J. 2021;57(4). https:\/\/doi.org\/10.1183\/13993003.01160-2020. PubMed PMID: 33093118.","DOI":"10.1183\/13993003.01160-2020"},{"issue":"2","key":"5057_CR10","first-page":"126","volume":"20","author":"R Bergner","year":"2003","unstructured":"Bergner R, Hoffmann M, Waldherr R, Uppenkamp M. Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2003;20(2):126\u201332. PubMed PMID: 12870722.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"issue":"12","key":"5057_CR11","first-page":"413","volume":"118","author":"HP Marti","year":"1988","unstructured":"Marti HP, Laissue J, Mihatsch M, Cottier H, Truniger B. [Renal manifestations of sarcoidosis]. Schweiz Med Wochenschr. 1988;118(12):413\u201321. PubMed PMID: 3287604.","journal-title":"Schweiz Med Wochenschr"},{"issue":"10","key":"5057_CR12","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/ndt\/gft442","volume":"29","author":"I Hilderson","year":"2014","unstructured":"Hilderson I, Van Laecke S, Wauters A, Donck J. Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options. Nephrol Dial Transpl. 2014;29(10):1841\u20137. https:\/\/doi.org\/10.1093\/ndt\/gft442.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5057_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1750-1172-8-65","volume":"8","author":"T Stehl\u00e9","year":"2013","unstructured":"Stehl\u00e9 T, Joly D, Vanhille P, Boffa JJ, R\u00e9my P, Mesnard L, et al. Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study. Orphanet J Rare Dis. 2013;8(1):65. https:\/\/doi.org\/10.1186\/1750-1172-8-65.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"5057_CR14","first-page":"306","volume":"31","author":"C L\u00f6ffler","year":"2015","unstructured":"L\u00f6ffler C, L\u00f6ffler U, Tuleweit A, Waldherr R, Uppenkamp M, Bergner R. Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 2015;31(4):306\u201315. PubMed PMID: 25591142.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"issue":"3","key":"5057_CR15","doi-asserted-by":"publisher","first-page":"e2021017","DOI":"10.36141\/svdld.v38i3","volume":"38","author":"F Rastelli","year":"2021","unstructured":"Rastelli F, Baragetti I, Buzzi L, Ferrario F, Benozzi L, Di Nardo F, et al. Renal involvement in sarcoidosis: histological patterns and prognosis, an Italian survey. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(3):e2021017. https:\/\/doi.org\/10.36141\/svdld.v38i3. 11488 PubMed PMID: 34744417; PubMed Central PMCID: PMC8552569.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"5057_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nephro.2021.08.001","volume":"18","author":"I Gorsane","year":"2022","unstructured":"Gorsane I, Zammouri A, Hajji M, Sallemi N, Aoudia R, Barbouch S, et al. Atteinte r\u00e9nale au cours de la sarco\u00efdose: facteurs pronostiques et pr\u00e9dictifs. N\u00e9phrologie Th\u00e9rapeutique. 2022;18(1):52\u20138. https:\/\/doi.org\/10.1016\/j.nephro.2021.08.001.","journal-title":"N\u00e9phrologie Th\u00e9rapeutique"},{"key":"5057_CR17","doi-asserted-by":"publisher","unstructured":"Mg R, Hs DBDH. Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2003;18(2). https:\/\/doi.org\/10.1093\/ndt\/18. 2.280 PubMed PMID: 12543881.","DOI":"10.1093\/ndt\/18"},{"issue":"3","key":"5057_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.36141\/svdld.v35i3.6655","volume":"35","author":"Y Kamata","year":"2018","unstructured":"Kamata Y, Sato H, Joh K, Tsuchiya Y, Kunugi S, Shimizu A, et al. Clinical characteristics of biopsy-proven renal sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):252\u201360. https:\/\/doi.org\/10.36141\/svdld.v35i3.6655. PubMed PMID: 32476910; PubMed Central PMCID: PMC7170156.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"5057_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfac227","volume":"38","author":"M Mahevas","year":"2023","unstructured":"Mahevas M, Audard V, Rousseau A, Cez A, Guerrot D, Verhelst D, et al. Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -. Eur Ren Assoc. 2023;38(4):961\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfac227. PubMed PMID: 36066903.","journal-title":"Eur Ren Assoc"},{"issue":"3","key":"5057_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/MD.0b013e3180699f55","volume":"86","author":"N Javaud","year":"2007","unstructured":"Javaud N, Belenfant X, Stirnemann J, Laederich J, Ziol M, Callard P, et al. Renal Granulomatoses: A Retrospective Study of 40 Cases and Review of the Literature. Med (Baltim). 2007;86(3):170. https:\/\/doi.org\/10.1097\/MD.0b013e3180699f55.","journal-title":"Med (Baltim)"},{"key":"5057_CR21","doi-asserted-by":"publisher","first-page":"205930071983492","DOI":"10.1177\/2059300719834928","volume":"5","author":"S Naderi","year":"2019","unstructured":"Naderi S, Amann K, Janssen U. Renal involvement in sarcoidosis: Histologic findings and clinical course. Nephrol Point Care. 2019;5:2059300719834928. https:\/\/doi.org\/10.1177\/2059300719834928.","journal-title":"Nephrol Point Care"},{"issue":"2","key":"5057_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","volume":"88","author":"M Mah\u00e9vas","year":"2009","unstructured":"Mah\u00e9vas M, Lescure FX, Boffa JJ, Delastour V, Belenfant X, Chapelon C, et al. Renal Sarcoidosis: Clinical, Laboratory, and Histologic Presentation and Outcome in 47 Patients. Med (Baltim). 2009;88(2):98. https:\/\/doi.org\/10.1097\/MD.0b013e31819de50f.","journal-title":"Med (Baltim)"},{"issue":"11","key":"5057_CR23","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2215\/CJN.03970510","volume":"5","author":"J Aouizerate","year":"2010","unstructured":"Aouizerate J, Matignon M, Kamar N, Thervet E, Randoux C, Moulin B, et al. Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol CJASN. 2010;5(11):2101\u20138. https:\/\/doi.org\/10.2215\/CJN.03970510. PubMed PMID: 20671220; PubMed Central PMCID: PMC3001780.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"634","key":"5057_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/pgmj.54.634.528","volume":"54","author":"ET MacSearraigh","year":"1978","unstructured":"MacSearraigh ET, Doyle CT, Twomey M, O\u2019Sullivan DJ. Sarcoidosis with renal involvement. Postgrad Med J. 1978;54(634):528\u201332. PubMed PMID: 733683; PubMed Central PMCID: PMC2425297.","journal-title":"Postgrad Med J"},{"issue":"2","key":"5057_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2215\/CJN.01790506","volume":"2","author":"N Joss","year":"2007","unstructured":"Joss N, Morris S, Young B, Geddes C. Granulomatous Interstitial Nephritis. Clin J Am Soc Nephrol. 2007;2(2):222. https:\/\/doi.org\/10.2215\/CJN.01790506.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"5057_CR26","doi-asserted-by":"publisher","first-page":"e110778","DOI":"10.1371\/journal.pone.0110778","volume":"9","author":"SM Bagnasco","year":"2014","unstructured":"Bagnasco SM, Gottipati S, Kraus E, Alachkar N, Montgomery RA, Racusen LC, et al. Sarcoidosis in Native and Transplanted Kidneys: Incidence, Pathologic Findings, and Clinical Course. PLoS ONE. 2014;9(10):e110778. https:\/\/doi.org\/10.1371\/journal.pone.0110778. PubMed PMID: 25329890; PubMed Central PMCID: PMC4203836.","journal-title":"PLoS ONE"},{"issue":"6","key":"5057_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4103\/1319-2442.275471","volume":"30","author":"A Zammouri","year":"2019","unstructured":"Zammouri A, Barbouch S, Najjar M, Aoudia R, Jaziri F, Kaaroud H, et al. Tubulointerstitial nephritis due to sarcoidosis: Clinical, laboratory, and histological features and outcome in a cohort of 24 patients. Saudi J Kidney Dis Transpl. 2019;30(6):1276. https:\/\/doi.org\/10.4103\/1319-2442.275471.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"Suppl 1","key":"5057_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5414\/CNP96S02","volume":"96","author":"M Frelih","year":"2021","unstructured":"Frelih M, Piko N, Ve\u010deri\u0107-Haler \u00c5, Kojc N, Bor\u0161tnar \u0160. Characteristics of renal sarcoidosis and tubulointerstitial nephritis and uveitis syndrome in Slovenia: An analysis of the national renal biopsy registry and patient datasets in the last decade. Clin Nephrol. 2021;96(Suppl 1):6\u201315. https:\/\/doi.org\/10.5414\/CNP96S02.","journal-title":"Clin Nephrol"},{"key":"5057_CR29","doi-asserted-by":"publisher","first-page":"107121","DOI":"10.1016\/j.rmed.2023.107121","volume":"209","author":"R Bergner","year":"2023","unstructured":"Bergner R, Weiner SM, Kehl G, De Groot K, Tielke S, Asendorf T, et al. Renal disease in sarcoidosis patients in a German multicentric retrospective cohort study. Respir Med. 2023;209:107121. https:\/\/doi.org\/10.1016\/j.rmed.2023.107121.","journal-title":"Respir Med"},{"issue":"10","key":"5057_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1159\/000530668","volume":"147","author":"M Zhu","year":"2023","unstructured":"Zhu M, Jiang L, Xu F, Hu J, Liang S, Zhang H. Clinicopathological Characteristics and Outcomes of Renal Sarcoidosis: A Series Study of 18 Patients from a Single Center. Nephron. 2023;147(10):591\u20138. https:\/\/doi.org\/10.1159\/000530668.","journal-title":"Nephron"},{"issue":"6","key":"5057_CR31","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.55730\/1300-0144.5907","volume":"54","author":"AB Di\u0307Ri\u0307M","year":"2024","unstructured":"Di\u0307Ri\u0307M AB, Suleymanova V, Hurdogan O, Oto \u00d6, Artan A, Ozturk S, et al. Clinicopathological features for the prediction of immunosuppressive treatment responses in sarcoidosis-related kidney involvement: a single-center retrospective study. Turk J Med Sci. 2024;54(6):1252\u201364. https:\/\/doi.org\/10.55730\/1300-0144.5907.","journal-title":"Turk J Med Sci"},{"issue":"9","key":"5057_CR32","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s10157-025-02688-7","volume":"29","author":"Y Kamata","year":"2025","unstructured":"Kamata Y, Konta T, Nakano T, Masuzawa N, Ichikawa K, Ozeki T, et al. Epidemiological study of renal involvement in sarcoidosis in Japan using the Japan Renal Biopsy Registry. Clin Exp Nephrol. 2025;29(9):1238\u201346. https:\/\/doi.org\/10.1007\/s10157-025-02688-7.","journal-title":"Clin Exp Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05057-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:06:36Z","timestamp":1785974796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05057-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5057"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05057-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was conducted within a UK tertiary NHS Trust as a service evaluation; under the Health Research Authority\u2019s UK Policy Framework for Health and Social Care Research and Governance Arrangements for Research Ethics Committees, such activity is not classified as research and does not require NHS REC review. Identifiable data were accessed only by clinicians with routine care access and anonymised before analysis, and in line with HRA information-governance guidance, individual consent was not required. The work was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"456"}}